Giving cancer patients aspirin at the same time as immunotherapy could dramatically boost the effectiveness of the treatment, according to new research published in the journal Cell today (Thursday).
Francis Crick Institute researchers, funded by Cancer Research UK, have shown that skin, breast and bowel cancer cells often produce large amounts of prostaglandin E2 (PGE2). This molecule dampens down the immune system’s normal response to attack faulty cells, which helps cancer to hide. It is a trick that allows the tumour to thrive and may explain why some immunotherapy treatments have not been as effective as hoped.
Aspirin is part of a group of molecules called COX inhibitors, which stop the production of PGE2 and help reawaken the immune system. Combining immunotherapy with aspirin or other COX inhibitors substantially slowed bowel and melanoma skin cancer growth in mice, compared to immunotherapy alone*.
Study author Professor Caetano Reis e Sousa, senior group leader at the Francis Crick Institute, said: “We’ve added to the growing evidence that some cancers produce PGE2 as a way of escaping the immune system. If you can take away cancer cells’ ability to make PGE2 you effectively lift this protective barrier and unleash the full power of the immune system.
“Giving patients COX inhibitors like aspirin at the same time as immunotherapy could potentially make a huge difference to the benefit they get from treatment. It’s still early work but this could help make cancer immunotherapy even more effective, delivering life-changing results for patients.”
The Latest on: Cancer immunotherapy
via Google News
The Latest on: Cancer immunotherapy
- Immunotherapy pioneer named American Association for Cancer Research Academy fellowon May 12, 2020 at 6:43 pm
Dr. Antoni Ribas was inducted into the group for his work in immunology and the development of new therapies for malignant melanoma.
- Nivolumab may help some patients with refractory biliary-tract canceron May 12, 2020 at 2:12 pm
Nivolumab appears to provide objective responses in selected patients with advanced refractory biliary-tract cancer, a nonrandomized study suggests.
- Biomarkers may predict response to immunotherapy in prostate canceron May 12, 2020 at 1:32 pm
Despite the success of immunotherapy in the treatment of patients with advanced malignancies, responses in metastatic castration-resistant prostate cancer have been limited. Cancers such as melanoma ...
- Clinical trial to evaluate two-drug immunotherapy combination in cancer patients with COVID-19on May 12, 2020 at 10:38 am
A unique two-drug immunotherapy combination first evaluated at Roswell Park Comprehensive Cancer Center as an approach for treating some cancers will soon be available to cancer patients with COVID-19 ...
- Cancer Immunotherapy Market 2020 Top Growing Companies, Structure Inspection and Forecast 2025on May 12, 2020 at 5:33 am
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Amgen ...
- New Study: Roswell Park to Assess Immunotherapy Combination in Cancer Patients With COVID-19on May 12, 2020 at 3:05 am
The U.S. Food and Drug Administration has authorized clinical researchers at Roswell Park Comprehensive Cancer Center to conduct a study assessing the safety and effectiveness ...
- Researchers identify checkpoint target for colorectal cancer immunotherapyon May 11, 2020 at 11:29 am
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified a target for colorectal cancer immunotherapy.
- Cancer-eating immune cells kitted out with CARson May 11, 2020 at 8:37 am
The scientific founders of Carisma Therapeutics, a startup aiming to equip phagocytes with a chimeric antigen receptor (CAR), reported in March that their engineered macrophages could infiltrate solid ...
- Worldwide Cancer Immunotherapy Market Size 2020 Structured with Competition Insights on Vendors, Revenue Estimates, and Regional Progress till 2025on May 6, 2020 at 3:49 am
Final Report will add the analysis of the impact of COVID-19 on this industry." “Cancer Immunotherapy Market” 2020 research report highlights top-vendors, specialized development structure, emerging ...
- Scientists turn the tables on cancer with new immunotherapy targeton April 30, 2020 at 1:40 am
One of the best weapons against cancer might have been inside us all along – our own immune systems. Immunotherapy involves supercharging the immune system to better root out cancer from its hiding ...
via Bing News